How can we best support those among us who’ve had recurrences or who have metastatic disease? If you have the ability and willingness, be an ally in breast cancer advocacy efforts.
I’ll never be able to eat a chocolate croissant and sip espresso while I sit and look out at the Eiffel Tower. But I’ve been able to start carving pieces out of a bucket list from home, surrounded by family.
You deserve to live well during breast cancer treatment. A common misconception is that palliative care is meant for end of life only. It’s different than hospice, though they both focus on quality of life for patients and their families.
I could not know what was to come for that woman sitting in the oncologist’s office nearly two years ago. I don’t know what the future holds. And I often wonder when the next worst day will be.
A young marriage with metastatic breast cancer shatters the illusions of growing old together. But love and laughter will keep you connected through the darkness and beyond.
The Metastatic Breast Cancer Access to Care Act HR 2178/S 1374 is in motion. We asked attorney Jennifer Berzok who works with the National Breast Cancer Coalition to explain the legislation.
As a young woman with metastatic cancer, even at the breast center I was an outlier in a field of healthy people, with healthy breasts, receiving screenings for a disease they don’t fully understand.
One of the most difficult parts of living with metastatic breast cancer in my thirties has been the challenge of explaining my symptoms and side effects. I don’t always fully understand them myself.
None of us knows how long we have left. Noticing details, becoming aware of our senses, being curious and having compassion for ourselves can all help anchor us here in the present.
At some point, young breast cancer survivors may experience the loss of a friend or member of their breast cancer community. The grief will feel like an emotional roller coaster. Because it is.
The Right to Try law allows terminally ill patients to request an investigational drug directly from a pharmaceutical company after Phase I clinical trials.
Questions and answers about leaving a legacy.
Mets-thriver Dikla Benzeevi reflects on her 15th cancerversary.